Scholtz & Company’s Spero Therapeutics SPRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-13,810	Closed	-$268K	–	83
2020 Q4	$268K	Buy	13,810 +480	+4%	+$9.32K	0.1%	69
2020 Q3	$149K	Buy	+13,330	New	+$149K	0.07%	66